5. årlige ECD Medical Symposium New York, NY
New York Medical Symposium gruppebilde 2017
Sammendrag av symposiet
Omtrent 65 medisinske fagpersoner fra åtte land deltok på det årlige medisinske ECD-symposiet i 2017. 18 muntlige sammendrag ble presentert, sammen med ytterligere fem posterpresentasjoner. Neal Rosen, MD, PhD, holdt et invitasjonsforedrag. En kveldsresepsjon ga tid til diskusjoner som støttet nåværende og fremtidige samarbeid blant denne svært kunnskapsrike gruppen av leger og forskere, alle interessert i å lære mer om Erdheim-Chester sykdom.
Programmer med agenda for symposiet
Presentasjoner
Følgende presentasjoner er lagt til i håp om at de vil hjelpe andre leger og forskere som er interessert i å lære mer om ECD. ECDGA er takknemlig for innsatsen og bidragene fra det medisinske miljøet for å forbedre behandlingen for ECD-pasienter.
| Presenter | Presentation Slides | English Video |
|---|---|---|
| Ankush Bhatia, MD | Single-agent dabrafenib for BRAFV600E-mutated histiocytosis | Not available. |
| Riccardo Biavasco, MD | BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis | Not available. |
| Pascale Chasseur, MD | A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid | Not available. |
| Marina Ferrarini, MD | 3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors | Not available. |
| Aaron Goodman, MD | Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy | Not available. |
| Gaurav Goyal, MBBS | Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease | Not available. |
| Gaurav Goyal, MBBS | Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease | Not available. |
| Julien Haroche, MD, PhD | BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort | Not available. |
| Filip Janku, MD, PhD | Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease | Not available. |
| Augusto Vaglio, MD | Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort | Not available. |
| Neal Rosen, MD, PhD | Not available. | Not available. |
| Juvianee Estrada-Veras, MD | Adult Patients with Mixed Histiocytosis: Cases from the NIH Clinical Center | Not available. |
| Benjamin H. Durham, MD | Genomic Analysis Identifies Novel Kinase Alterations in the Histiocytic Neoplasms | Not available. |
| Domenico Corradi, MD | Pro-Collagen Type I Expression In Foamy Histiocytes From Erdheim-Chester Disease Biopsies | Not available. |
| Eli L. Diamond, MD | Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Disorders: Interim Results | Not available. |
| Disha Dalela, MBBS | The Masquerader- ECD presenting as PUO | Not available. |
| Rahul H. Dave, MD, PhD | Neurologic Involvement in Erdheim-Chester Disease | Not available. |
| S. Mojdeh Mirmomen and Moozhan Nikpanah | Abdominal and Thoracic Imaging Presentations of 61 Cases of ECD: Association with BRAFV600E Mutation | Not available. |
| Roei Mazor, MD | Comparative Analysis of Tandem PET/CT & PET/MR Studies in the Evaluation of Patients with Inflammatory Myeloid Neoplasms | Not available. |
| Eli L. Diamond, MD | IMPACT: MSKCC targeted tumor sequencing test available for ECD patients | Not available. |
| Eli L. Diamond, MD | Update Consensus Guidelines | Not available. |
| Mark Heaney, MD, PhD, Eli L. Diamond, MD, Kathleen Brewer | Closing | Not available. |
Fotografier
Medisinsk symposium
Medisinsk resepsjon
Følgende bilder ble tatt under ECD Medical Symposium den 27. oktober i New York, NY. Takk til alle deltakere og foredragsholdere for en givende og opplysende opplevelse ved dette arrangementet. Vennligst bli med oss igjen den 15. november 2018 i Orlando! Se også siden for pasient- og pårørendesamling for mer informasjon.
